60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP)
60 Degrees Pharmaceuticals, Inc. (SXTP) is a biopharmaceutical company focused on developing innovative therapies primarily targeting cancer and other serious medical conditions. The company emphasizes research and development to bring novel treatment options to market, leveraging advanced scientific approaches to improve patient outcomes.
Company News
60 Degrees Pharmaceuticals Expands Options for Malaria Prevention with Introduction of ARAKODA® (tafenoquine) 8-Count Bottle Format
60 Degrees Pharmaceuticals has introduced a new 8-count bottle format for its malaria prevention drug ARAKODA, expanding options for healthcare professionals and travelers.
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
U.S. stock futures were mixed ahead of the Federal Reserve's interest rate decision and key earnings reports from major tech companies. Investors are cautious as they await the Fed's policy announcement and guidance.